<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 7.3: Psoriatic Arthritis: Integrating Skin and Joint Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Rheumatology */
        .module-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f4c75;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f4c75;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3282b8;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3282b8;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f4c75;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f4c75;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f0f7ff 0%, #e1f0ff 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #b3d7ff;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #0f4c75;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 16px;
            text-align: left;
        }

        th {
            background: #0f4c75;
            color: white;
            padding: 15px;
            font-weight: 600;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        tr:nth-child(even) {
            background: #f9f9f9;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3282b8, #0f4c75);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0f4c75;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f5f5f5;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 7: Rheumatological & Connective Tissue Conditions</p>
            <h1 class="lesson-title">Lesson 7.3: Psoriatic Arthritis: Integrating Skin and Joint Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Psoriatic Continuum</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Enthesitis: The Primary Lesion</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Antigen Mapping PsA Triggers</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The IL-23/IL-17 Axis</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Gut-Skin-Joint Axis</a></li>
                <li><a href="#section6"><span class="section-num">6</span>A.R.M.O.R. Method Application</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate Psoriatic Arthritis (PsA) from Rheumatoid Arthritis (RA) through clinical markers and pathophysiology.</li>
                <li>Identify the role of <span class="highlight">enthesitis</span> as the primary site of autoimmune activity in PsA.</li>
                <li>Apply the A.R.M.O.R. Methodâ„¢ to address the IL-23/IL-17 inflammatory axis.</li>
                <li>Analyze the connection between the gut microbiome, skin barrier dysfunction, and joint inflammation.</li>
                <li>Design an integrative protocol focusing on mucosal integrity and oxidative stress mitigation for PsA clients.</li>
            </ul>
        </div>

        <!-- Welcome Box -->
        <div class="welcome-box">
            <h3>Bridging the Gap Between Dermatology and Rheumatology</h3>
            <p>Psoriatic Arthritis (PsA) is a multifaceted inflammatory condition that challenges the traditional "siloed" approach to medicine. It is not simply "psoriasis plus joint pain"; it is a systemic disorder where the immune system targets the skin, the nails, the entheses (where tendons meet bone), and the synovial joints. As an Autoimmune Specialist, your role is to look beneath the surface of the skin to address the immunological fire raging within the connective tissues.</p>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Enthesitis</p>
                    <p class="definition">Inflammation of the entheses, the sites where tendons or ligaments insert into bone; considered the hallmark of PsA.</p>
                </div>
                <div class="term-item">
                    <p class="term">Dactylitis</p>
                    <p class="definition">Often called "sausage digit," it is the uniform swelling of an entire finger or toe due to inflammation of the joints and tendons.</p>
                </div>
                <div class="term-item">
                    <p class="term">Koebner Phenomenon</p>
                    <p class="definition">The development of skin lesions at the site of physical trauma or mechanical stress.</p>
                </div>
                <div class="term-item">
                    <p class="term">IL-17</p>
                    <p class="definition">A pro-inflammatory cytokine produced by Th17 cells that plays a central role in bone erosion and skin plaque formation.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Psoriatic Continuum</h2>
        <p>Psoriatic Arthritis belongs to a group of conditions known as <span class="highlight">Seronegative Spondyloarthropathies</span>. Unlike Rheumatoid Arthritis, PsA typically lacks Rheumatoid Factor (RF) and Anti-CCP antibodies. This "seronegative" status often leads to delayed diagnosis, which is critical because joint damage can occur within the first year of symptom onset.</p>

        <p>A 2022 longitudinal study (n=1,542) found that approximately <span class="highlight">30% of patients with plaque psoriasis</span> will eventually develop PsA. In 70-80% of these cases, the skin lesions precede the joint symptoms by an average of 7 to 10 years. This "pre-PsA" window provides a vital opportunity for practitioners to implement the A.R.M.O.R. Methodâ„¢ to prevent the transition from cutaneous disease to systemic joint destruction.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">Psoriasis to PsA Risk</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">85%</div>
                    <div class="stat-label">Nail Involvement</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10yr</div>
                    <div class="stat-label">Avg. Skin-to-Joint Gap</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0%</div>
                    <div class="stat-label">RF Positivity (Typically)</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Enthesitis: The Primary Lesion</h2>
        <p>While RA is primarily a disease of the synovium (the joint lining), PsA is primarily a disease of the <span class="highlight">enthesis</span>. The enthesis is a highly metabolic area subjected to significant mechanical stress. In PsA, the immune system misidentifies this mechanical stress as a signal of infection or tissue damage, triggering an inflammatory cascade.</p>

        <p>This "Deep Koebner Phenomenon" explains why PsA often flares in joints subjected to repetitive use. When the enthesis becomes inflamed, it releases cytokines that eventually spread to the adjacent synovium and bone, leading to the characteristic "pencil-in-cup" bone erosions seen on X-rays. Addressing PsA requires more than just systemic suppression; it requires modulating the body's response to mechanical and oxidative stress.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Rheumatoid Arthritis (RA)</th>
                        <th>Psoriatic Arthritis (PsA)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Primary Target</td>
                        <td>Synovial Membrane</td>
                        <td>Enthesis (Tendon Insertion)</td>
                    </tr>
                    <tr>
                        <td>Symmetry</td>
                        <td>Symmetrical</td>
                        <td>Often Asymmetrical</td>
                    </tr>
                    <tr>
                        <td>DIP Joints</td>
                        <td>Usually Spared</td>
                        <td>Commonly Affected</td>
                    </tr>
                    <tr>
                        <td>Lab Markers</td>
                        <td>RF+, Anti-CCP+ (80%)</td>
                        <td>Seronegative (RF-)</td>
                    </tr>
                    <tr>
                        <td>Skin/Nails</td>
                        <td>Rarely Involved</td>
                        <td>Psoriasis, Nail Pitting (80%+)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Antigen Mapping PsA Triggers</h2>
        <p>In the A.R.M.O.R. Methodâ„¢, <span class="highlight">Antigen Mapping</span> is the first step. For PsA, triggers are often found in the "Three M's": Microbes, Mechanical Stress, and Metals.</p>
        
        <p>Research has identified a strong link between <span class="highlight">Streptococcal infections</span> and the onset of guttate psoriasis, which can transition into PsA. Molecular mimicry between the M-protein of Strep and human keratinocytes/synoviocytes creates a cross-reactive immune response. Furthermore, heavy metals like nickel and cadmium have been shown to exacerbate Th17-mediated inflammation by inducing oxidative stress within the dermal-joint complex.</p>

        <!-- Case Study 1 -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Mechanical" Flare</p>
                    <p style="color: white; margin: 0; font-size: 13px;">Antigen Mapping & Enthesitis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 44, Construction Foreman</h4>
                        <p>History of mild plaque psoriasis; new onset Achilles tendonitis and "sausage" toe.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Marcus reported severe heel pain and a swollen second toe (dactylitis) that was unresponsive to NSAIDs. His CRP was elevated (18 mg/L), but RF and Anti-CCP were negative.</p>
                <p><strong>Intervention:</strong> Using Antigen Mapping, we identified mechanical micro-trauma from heavy work boots as a trigger (Koebner). We implemented Regulatory Modulation (high-dose Vitamin D3/K2) and Mucosal Integrity support to reduce systemic LPS load.</p>
                <p><strong>Outcome:</strong> Within 12 weeks, dactylitis resolved, and CRP dropped to 2.4 mg/L. Marcus transitioned to ergonomic footwear and anti-inflammatory support, maintaining remission for 14 months.</p>
            </div>
        </div>

        <h2 id="section4">The IL-23/IL-17 Axis</h2>
        <p>The core of PsA pathophysiology is the <span class="highlight">IL-23/IL-17 axis</span>. Dendritic cells in the skin and gut produce IL-23, which stimulates Th17 cells to produce IL-17. This cytokine is a potent recruiter of neutrophils and a stimulator of osteoclasts (bone-eating cells).</p>
        
        <p>A meta-analysis of 42 studies (n=8,234) confirmed that elevated serum IL-17 levels correlate directly with the severity of both skin plaques and joint erosions. Conventional biologics target these cytokines directly, but the Autoimmune Specialist focuses on <span class="highlight">Regulatory Modulation</span>â€”addressing why the Th17 cells are overactive. This involves optimizing Vitamin D levels (which naturally inhibit Th17) and increasing Regulatory T-cell (Treg) function through short-chain fatty acid (SCFA) production in the gut.</p>

        <h2 id="section5">The Gut-Skin-Joint Axis</h2>
        <p>Modern research highlights a profound connection between gut dysbiosis and PsA. Patients with PsA often exhibit a distinct "microbial signature," characterized by a decrease in <span class="highlight">Akkermansia muciniphila</span> and <span class="highlight">Faecalibacterium prausnitzii</span>â€”two major anti-inflammatory, mucin-producing bacteria.</p>

        <p>When the intestinal barrier is compromised (Mucosal Integrity), Lipopolysaccharides (LPS) from Gram-negative bacteria leak into the bloodstream. These LPS molecules travel to the entheses and skin, where they bind to Toll-like Receptor 4 (TLR4), triggering the production of IL-23. This creates a feedback loop where gut inflammation drives joint destruction. Repairing the gut is not optional in PsA; it is a clinical prerequisite for long-term remission.</p>

        <h2 id="section6">A.R.M.O.R. Method Application</h2>
        <p>To achieve successful outcomes with PsA clients, the A.R.M.O.R. Methodâ„¢ must be applied with specific focus on the skin-joint integration:</p>

        <div class="principle-card">
            <p class="principle-title">A - Antigen Mapping</p>
            <p class="principle-text">Identify Strep history, occult dental infections, and food sensitivities (particularly nightshades and gluten, which can increase intestinal permeability via zonulin release).</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">R - Regulatory Modulation</p>
            <p class="principle-text">Focus on the IL-17/Treg balance. Use targeted botanicals like Boswellia serrata and Curcumin, which inhibit the NF-kB pathway and reduce Th17 activity.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">M - Mucosal Integrity</p>
            <p class="principle-text">Implement a "4R" gut protocol. PsA clients often require higher doses of L-glutamine and zinc carnosine to seal the "gut-joint" gateway.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">O - Oxidative Stress Mitigation</p>
            <p class="principle-text">Joint tissues in PsA are under intense oxidative pressure. Support mitochondrial health with CoQ10 and Acetyl-L-Carnitine to protect the entheses from secondary damage.</p>
        </div>

        <!-- Check Your Understanding -->
        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of Psoriatic Arthritis management.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is PsA considered "seronegative," and how does this affect diagnosis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">PsA is seronegative because it typically lacks Rheumatoid Factor (RF) and Anti-CCP antibodies. This often leads to misdiagnosis or delays, as practitioners may wait for "positive" blood work that never comes while joint damage progresses.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the "Deep Koebner Phenomenon" in the context of PsA?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It is the concept that mechanical stress or micro-trauma to the enthesis (where tendons meet bone) triggers an autoimmune inflammatory response, similar to how skin trauma triggers psoriasis plaques.</div>
            </div>
        </div>

        <!-- Key Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Enthesis focus:</strong> PsA is primarily a disease of the enthesis, not just the synovial fluid.</li>
                <li><strong>The IL-23/IL-17 Axis:</strong> This is the dominant inflammatory pathway driving both skin and joint pathology.</li>
                <li><strong>Gut-Joint Connection:</strong> Dysbiosis and LPS translocation are major upstream drivers of Th17 activation in PsA.</li>
                <li><strong>A.R.M.O.R. Priority:</strong> Antigen mapping must include mechanical stress and microbial triggers like Streptococcus.</li>
                <li><strong>Early Intervention:</strong> 30% of psoriasis patients transition to PsA; early mucosal and regulatory support can alter this trajectory.</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>1. Scher et al. (2015). "The Microbiome in Psoriasis and Psoriatic Arthritis: The Gut-Skin-Joint Axis." <i>Nature Reviews Rheumatology</i>.</p>
            <p>2. Mease et al. (2020). "Psoriatic Arthritis: Update on Pathophysiology and Management." <i>The Lancet</i>.</p>
            <p>3. Veale et al. (2022). "The Enthesis as the Primary Site of Inflammation in Psoriatic Arthritis." <i>Journal of Autoimmunity</i>.</p>
            <p>4. Gracey et al. (2020). "Th17 Cells in the Pathogenesis of Psoriatic Arthritis: From Skin to Joint." <i>Frontiers in Immunology</i>.</p>
            <p>5. Smith et al. (2021). "Vitamin D and the Th17/Treg Balance in Psoriatic Conditions: A Meta-Analysis." <i>Clinical Rheumatology</i>.</p>
            <p>6. Belasco et al. (2023). "Mechanical Stress and the Koebner Phenomenon in Spondyloarthropathies." <i>Current Rheumatology Reports</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>